Investor Stock List
Ranked #1,756 of 8,699 institutional investors

Affinity Asset Advisors, LLC

New York, NY

$1.60B
US stock portfolio at live prices · today +$11.2M (+0.70%)
Market closed. Prices as of Nov 20, 7:11 AM ET
Value at quarter end (Q3 2026)
$1.72B
Change from Q2 2026
−$294.8M (−14.62%)
Positions
84 · 18 new, 10 sold out
Filed
Nov 13, 2026

Not counted in the ranking: call options on $131M of stock, put options on $564M, $41.0M of convertible notes and other principal-amount securities. $277M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
SYRE 7.81%TRAX 5.78%INSM 5.10%ERAS 4.97%XENE 4.47%
StockSharesValue, live% of portfoliovs Q2 2026
SYRE Spyre Therapeutics, Inc.1,279,134$125M7.81%Unchanged
TRAX First Tracks Biotherapeutics, Inc.2,080,000$92.5M5.78%Added +2%
INSM Insmed Incorporated564,251$81.5M5.10%Reduced −13%
ERAS Erasca, Inc.5,590,600$79.5M4.97%Added +6%
XENE Xenon Pharmaceuticals Inc.1,900,374$71.4M4.47%Added +19%
ORKA Oruka Therapeutics, Inc.600,000$58.5M3.66%Added +2%
PRAX Praxis Precision Medicines, Inc.155,000$48.2M3.01%Reduced −16%
CYTK Cytokinetics, Incorporated750,000$38.6M2.41%Added +36%
BLTE Belite Bio, Inc242,088$36.6M2.29%Added +47%
RVMD Revolution Medicines, Inc.225,000$35.9M2.24%Reduced −10%
CLDX Celldex Therapeutics, Inc.1,160,499$32.4M2.03%Added +66%
DNTH Dianthus Therapeutics, Inc.350,000$29.7M1.86%Reduced −13%
ABVX ABIVAX Société Anonyme330,000$26.6M1.66%Unchanged
TRVI Trevi Therapeutics, Inc.1,800,172$24.7M1.55%Unchanged
SGMT Sagimet Biosciences Inc.2,527,384$24.3M1.52%Added +1%
OVID Ovid Therapeutics Inc.10,144,562$23.7M1.48%Unchanged
ODTX Odyssey Therapeutics, Inc.1,260,000$23.1M1.45%Added +64%
AVTX Avalo Therapeutics, Inc.3,244,861$21.9M1.37%Added +12%
LXEO Lexeo Therapeutics, Inc.7,245,611$21.4M1.34%Added +25%
PTGX Protagonist Therapeutics, Inc.172,125$21.3M1.34%Unchanged
ARWR Arrowhead Pharmaceuticals, Inc.425,000$18.6M1.16%Added +183%
ANRO Alto Neuroscience Inc643,343$17.1M1.07%Reduced −24%
TYRA Tyra Biosciences, Inc.850,000$16.8M1.05%Added +325%
COAG Hemab Therapeutics Holdings, Inc.420,000$16.7M1.05%Added +204%
TVTX Travere Therapeutics, Inc.300,000$14.5M0.91%Unchanged
ARVN Arvinas, Inc.2,050,000$13.8M0.86%New
RLAY Relay Therapeutics, Inc.850,000$13.5M0.85%Reduced −19%
NRIX Nurix Therapeutics, Inc.967,620$13.2M0.82%Unchanged
SVRA Savara Inc.2,512,153$13.1M0.82%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.30,000$11.9M0.74%Reduced −25%
VOGX Vogenx, Inc.915,000$11.7M0.73%New
JBIO Jade Biosciences, Inc.760,350$11.5M0.72%Reduced −10%
MLYS Mineralys Therapeutics, Inc.750,000$10.6M0.66%Unchanged
EPRX Eupraxia Pharmaceuticals Inc.1,716,320$10.5M0.66%Added +4%
STRO Sutro Biopharma, Inc.1,152,487$10.0M0.63%Reduced −2%
MANE Veradermics Inc79,400$9.9M0.62%Reduced −21%
BEAM Beam Therapeutics Inc.450,000$9.4M0.59%New
KRSA Korsana Biosciences, Inc.263,106$9.3M0.58%New
CLYM Climb Bio Inc972,000$9.0M0.56%Unchanged
SLN Silence Therapeutics plc450,000$8.9M0.56%New
PRLD Prelude Therapeutics Incorporated2,600,000$8.5M0.53%New
CGEM Cullinan Therapeutics, Inc.875,760$7.9M0.50%Unchanged
AMLX Amylyx Pharmaceuticals, Inc.300,000$7.9M0.49%Added +203%
VRDN Viridian Therapeutics, Inc.250,000$7.9M0.49%Unchanged
IBRX ImmunityBio, Inc.1,180,000$7.8M0.48%New
ELVN Enliven Therapeutics, Inc.148,000$6.9M0.43%Reduced −70%
VERA Vera Therapeutics, Inc.250,000$6.7M0.42%Unchanged
KRRO Korro Bio, Inc.531,904$6.5M0.41%Reduced −25%
XFOR X4 Pharmaceuticals, Inc.2,062,500$6.1M0.38%Added +1,322%
AKTS Aktis Oncology, Inc.350,000$5.7M0.36%New
IDYA IDEAYA Biosciences, Inc.200,000$5.2M0.33%Reduced −50%
AVR Anteris Technologies Global Corp.912,397$4.6M0.29%Unchanged
DTIL Precision BioSciences, Inc.646,576$4.5M0.28%Unchanged
SABS SAB Biotherapeutics, Inc.1,525,000$4.4M0.28%Unchanged
RZLT Rezolute, Inc.1,000,000$4.2M0.26%Unchanged
TSHA Taysha Gene Therapies, Inc.1,000,000$3.8M0.24%Reduced −43%
IRD Opus Genetics, Inc.900,000$3.7M0.23%New
NTLA Intellia Therapeutics, Inc.350,000$3.3M0.21%New
LTGO Latigo Biotherapeutics, Inc.250,000$3.3M0.21%New
IBIO iBio, Inc.4,130,427$3.3M0.21%Added +3%
IMVT Immunovant, Inc.100,000$3.3M0.20%Unchanged
ANAB AnaptysBio, Inc.66,464$3.2M0.20%Reduced −92%
CATX Perspective Therapeutics, Inc.3,988,744$3.1M0.20%Reduced −5%
ARKG ARK Genomic Revolution ETF74,900$3.0M0.19%New
EQ Equillium, Inc.2,613,954$2.9M0.18%Reduced −36%
MBX MBX Biosciences, Inc.50,000$2.7M0.17%Reduced −33%
CMPS COMPASS Pathways plc301,183$2.6M0.16%Unchanged
SLDB Solid Biosciences Inc.400,000$2.6M0.16%New
PMVP PMV Pharmaceuticals, Inc.1,750,000$2.3M0.14%New
VRCA Verrica Pharmaceuticals Inc.688,654$2.0M0.12%Reduced −3%
NXTC NextCure, Inc.291,960$2.0M0.12%Added +596%
MGNX MacroGenics, Inc.953,979$1.9M0.12%Reduced −22%
NMRA Neumora Therapeutics, Inc.4,500,000$1.6M<0.1%Added +320%
EIKN Eikon Therapeutics, Inc.298,001$1.4M<0.1%Added +204%
ANL Adlai Nortye Group Ltd.153,847$1.4M<0.1%Unchanged
FTH Faeth Therapeutics, Inc.144,404$1.3M<0.1%Unchanged
AVBP ArriVent BioPharma, Inc.100,000$1.1M<0.1%Reduced −20%
SPRO Spero Therapeutics, Inc.1,300,000$1.1M<0.1%New
GENB Generate Biomedicines, Inc.100,000$1.0M<0.1%Reduced −75%
LENZ LENZ Therapeutics, Inc.300,000$1.0M<0.1%Added +200%
SLS SELLAS Life Sciences Group, Inc.50,000$743K<0.1%New
FDMT 4D Molecular Therapeutics, Inc.50,000$536K<0.1%New
QTTB Q32 Bio Inc.27,777$236K<0.1%Unchanged
ENTA Enanta Pharmaceuticals, Inc.29,300$234K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
COGT Cogent Biosciences, Inc.450,000$12.5M
ASMB Assembly Biosciences, Inc.190,000$4.3M
SGP SpyGlass Pharma, Inc.131,586$4.1M
ALEC Alector, Inc.1,510,000$3.5M
SPRB Spruce Biosciences, Inc.30,000$1.2M
ENGN enGene Therapeutics Inc.600,000$1.1M
OKUR OnKure Therapeutics, Inc.240,963$665K
BOLD Boundless Bio, Inc.250,000$595K
OBIO Orchestra BioMed Holdings, Inc.33,400$234K
KPTIQ Karyopharm Therapeutics Inc.312,500$11K